Avicenna Oncology GmbH

Avicenna Oncology is a start-up dedicated to the scouting acquisition & development of new generation of payloads for oncology targeted therapeutics. Avicenna Oncology has been created with the purpose to combine both precision medicine and drug conjugates against resistant cancers, as cancer drug resistance is still a major impediment (ex. about 30% breast cancer patients end up refractory). The cause of that are mainly resistance mechanisms. The goal of Avicenna is to enhance privat lives in combining precision medicine and drug conjugates approach.